Webinar: BioTechX: AI in early Drug Discovery: From Promise to Practice

Wednesday, May 18, 10:30am - 11:30am (EDT)

Time shown in-04:00 America, New York

Register here

Join Jeff Blaney (Genentech), Darren Green (GSK) Julian Levell (New Equilibrium Biosciences) and Matt Segall (Optibrium), for this panel on the state of AI in early drug discovery from hit to preclinical candidate. The panellists will share their experiences with and expectations of AI, including predictive modelling, synthesis prediction and generative chemistry. Hear about the successes of AI and an outlook on what AI needs to achieve to really transform drug discovery.

BioTechX
Optibrium

Add to Calendar 2022/05/18 15:30:00 2022/05/18 16:30:00 Europe/London Webinar: BioTechX: AI in early Drug Discovery: From Promise to Practice Register here

Join Jeff Blaney (Genentech), Darren Green (GSK) Julian Levell (New Equilibrium Biosciences) and Matt Segall (Optibrium), for this panel on the state of AI in early drug discovery from hit to preclinical candidate. The panellists will share their experiences with and expectations of AI, including predictive modelling, synthesis prediction and generative chemistry. Hear about the successes of AI and an outlook on what AI needs to achieve to really transform drug discovery.

BioTechX
Optibrium false MM/DD/YYYY 2880 OPAQUE aTKoOxaSNzzbKycOVmQP156172

Ollie McDaid, ollie.mcdaid@Terrapinn.com

Link: